CD27 and CD134 ligand (CD134L) are two B cell co-receptors for T h cell activation-induced ligands (i.e. CD70 and CD134) that promote differentiation of B cells into plasma cells and high-rate antibody production respectively. We explored the CD27 pathway and T cell CD134 expression in common variable immunodeficiency (CVID), a disease characterized by a lack of plasma cells and low Ig serum levels. Twelve patients were compared to seven healthy controls. We found a low percentage of circulating CD27 ⍣ B cells in seven patients and B cell CD27 expression was not upregulated by in vitro activation in two of them. Importantly, the number of circulating CD27 ⍣ B cells was correlated with the severity of the disease-the patients with the lowest CD27 ⍣ B cell counts having the lowest serum Ig concentrations and the lowest total peripheral blood B cell counts. In contrast, CD70 and CD134 were normally expressed on in vitro activated T cells. CD134L was not detected on patient and control B cells in our activation conditions. Functional studies of in vitro Ig production demonstrated an absence of B cell response to CD27 cross-linking, in particular in a patient with normal CD27 expression. Our results indicate that a defect in CD27 expression or function contributes to the pathogenesis of certain severe forms of CVID.
Introduction
Common variable immunodeficiency (CVID), the most fre-(2). However, identification of a precise molecular basis for the disease remains so far elusive and it is likely that CVID is quent symptomatic primary antibody deficiency syndrome in humans, is characterized by a marked reduction in Ig serum a syndrome including different diseases (3). Nevertheless, common features in CVID are defects in terminal B cell levels, recurrent bacterial infections, and increased occurrence of autoimmune diseases and malignancies (1). Patients differentiation resulting in a lack of plasma cells in tissue sites. B cell activation and differentiation depend upon cognate have low to normal numbers of circulating B cells with frequent defects in their capacity to differentiate in response to various T cell-B cell interactions involving several ligand-receptor pairs on both cell types and cytokine production. We and stimuli. T cell dysfunction has also been shown in CVID, in particular a decreased production of IL-2, IL-4, IL-5 and IFN-γ others have previously demonstrated that interaction between the B cell co-receptor CD27 and its ligand, CD70, on activated The 5A8 anti-CD134L (IgG1) (18) and the CD3 (OKT3, IgG2a) (21) mAb were produced locally. T h cells plays a critical role in T cell-dependent B cell differentiation into plasma cells (4) (5) (6) (7) (8) (9) . Moreover, CD27 was
Cell isolation and culture recently identified as a marker of memory B cells (10, 11) , a B cell subset prone to differentiation into plasma cells (12, 13) .
Peripheral blood mononuclear cells (PBMC) were isolated CD27 is a member of the tumor necrosis factor (TNF) receptor by Ficoll-Hypaque (Pharmacia, Uppsala, Sweden) densityfamily (14) . This family includes other important molecules gradient centrifugation and depleted of monocytes by adhercontrolling B cell fate that can promote either differentiation ence to the plastic surface of culture dishes. For some towards germinal center cells and memory B cells such as experiments, B cells were further purified by positive magnetic CD40 (15) , apoptosis such as CD95 (16) or survival such as selection with CD22 mAb-coated beads (Miltenyi, Bergisch BCMA (B cell maturation antigen) (17) . In addition to CD27, Gladbach, Germany) according to the manufacturer's instrucwe recently found that CD134 ligand (CD134L), a member of tions. More than 95% of the cells obtained expressed CD19 the reciprocal family of ligands related to TNF, after crossas assessed by flow cytometry. PBMC (10 6 /ml) were cultured linking with CD134 expressed on activated T cells, also at 37°C with 5% CO 2 and 95% humidified air in 12-well plates delivers to B cells signals enhancing antibody production in (Costar, Cambridge, MA) coated with CD3 mAb in RPMI 1640 humans (18) as previously shown in mice (19, 20) . These supplemented with 10% FCS and antibiotics (Life Technoloobservations prompted us to investigate the CD27-CD70 and gies, Gaithersburg, MD). The kinetics of cell-surface molecule CD134L-CD134 pathways in CVID. Our results do not provide expression (CD27, CD70 and CD134) during lymphocyte evidence for an abnormal regulation of CD134 expression on activation was followed by flow cytometry from day 0 to 5. patient T cells. In contrast, we show here that CD27 is poorly expressed or not functional on B cells of a subset of CVID Flow cytometry patients presenting a severe immunodeficiency, whereas their Cells were labeled with FITC-or phycoerythrin (PE)-conjug-T cells have normal CD27 expression and high or normal ated mAb and flow cytometry analysis was performed on CD70 expression.
an Epics Elite flow cytometer (Coulter, Hialeah, FL). The lymphocyte population was identified in forward/sideward scatter and fluorescence intensity data were collected on 10 4 Methods gated lymphocytes. Isotype-matched mouse IgG (Coulter) Patients and controls negative controls were used throughout the studies and always reacted with Ͻ5% of the cells. Twelve CVID patients were studied (Table 1 ). All patients had a history of recurrent bacterial infection of the upper and
In vitro IgG production and quantification by ELISA lower respiratory tracts, and all of them were treated with monthly i.v. Ig infusions. Seven healthy volunteers (age 24-For some patients and controls, purified B cells (10 6 /ml) were 40 years) were also analyzed. Blood samples were obtained cultured in triplicates in 96-well round-bottom plates in 0.2 ml after informed consent from patients and controls.
of culture medium with formalinized Staphylococcus aureus Cowan I strain (SAC) (Pansorbin; Calbiochem, San Diego, mAb CA) (1:5000, v/v) and IL-2, 30 U/ml. The previously described (22,23) CD70 cDNA-transfected cells, CD70/300-19, or vector The following fluorochrome-labeled mAb were obtained from commercial sources: CD3 (UCHT1, IgG1), CD19 (B4, IgG1), alone-transfected cells, mock/300-19, were added to the culture (2.5ϫ10 4 cells/well) to provide CD27 cross-linking or CD27 (1A4, IgG1) and CD70 (2F11, IgG1) (Coulter, Miami, FL), and CD134 (ACT35, IgG1) (PharMingen, San Diego, CA).
as a negative control respectively. The CD70/300-19 and PBMC from all patients and controls were stained with FITC-CD19 and PE-CD27 mAb, and analyzed by flow cytometry as indicated in methods.
CD27 was measured by two-color flow cytometry in all patients and controls ( Fig. 1 ). Seven out of 12 patients had a percentage of CD27 ϩ B cells lower than controls (below the mean ing CD27 ϩ T cells (data not shown and Fig. 1 had the most severe clinical appearance, with B cell lymphopenia and dramatically reduced serum IgG levels at the time of diagnosis (Table 1) . mock/300-19 cell lines were maintained in culture medium
Since in vitro activation can induce CD27 expression on B supplemented with G418 (Life Technologies) and fixed with cells of normal individuals (4), we examined the kinetic of 1% paraformaldehyde in PBS for 5 min before being added CD27 on activated B cells of CVID patients, in particular of to the B cell culture.
those with reduced numbers of CD27 ϩ B cells. PBMC were After 7 days, culture supernatants were harvested and cultured on CD3 mAb-coated plates, leading to B cell stimulaadded to goat anti-human Ig (Caltag, Burlingame, CA)-coated tion by CD3-activated T cells, as previously described (24). 96-well flat-bottom ELISA plates. After discarding superNo increase of CD27 ϩ B cells was observed in patients AK natants and washing with 0.05% Tween 20 in PBS, the bound and BG, who had the lowest CD27 ϩ B cell percentages (Fig. IgG were detected with biotinylated goat anti-human IgG 3). However, flow cytometric analysis still showed viable B (Caltag) at a dilution of 1/10,000), followed by addition of cells in PBMC cultures from these two patients. Patient DG alkaline phosphatase-labeled streptavidin (1/3000) and could not be tested. All the other four patients with a low p-nitrophenyl phosphate (Sigma, St Louis, MO) substrate. The circulating CD27 ϩ B cell population and patients with normal amount of bound IgG was assessed by spectrophotometric numbers of CD27 ϩ B cells showed a kinetic profile of CD27 analysis at 405 nm.
up-regulation on B lymphocytes similar to that observed in the seven healthy controls (Fig. 3) .
Results

Normal or increased CD70 expression and normal CD134 expression on in vitro activated T cells of CVID patients Reduced expression of CD27 on circulating B cells of a subgroup of CVID patients
Next, we asked whether the expression pattern of the CD27 ligand, CD70, on resting and activated T cells is similar in CD27, a critical differentiation marker acquired during peripheral B cell maturation and driving differentiation into plasma CVID patients and controls. CD70 was not expressed on resting T cells in all patients and controls. The kinetic study cells, identifies the memory B cell population, which constitutes~30% of circulating B cells in healthy adults. The of CD70 expression on CD3-activated T cells was performed in all patients and controls, and showed that patient T cells percentage of peripheral blood CD19 ϩ B cells expressing expressed CD70 at similar or higher proportions than control T cells (Fig. 4A) .
CD134 is another activation-induced T cell surface molecule promoting Ig secretion by plasma cells (18) . All patient T lymphocytes displayed the same kinetics of CD134 expression as all control T cells (Fig. 4B) . CD134L, the CD134 counter-receptor on B cells, could not be induced in our 
certain CVID patients
Since we did not find a lack of CD70 or CD134 expression on activated T cells that could pinpoint for a defective T h cell function, we considered that, so far, the major defect observed is a decreased B cell CD27 expression in more than half of CVID patients. To further investigate possible CD27 defects in CVID, we looked for a functional abnormality of the CD27 signaling pathway and measured the in vitro Ig production in response to CD27 engagement. Purified B cells from four representative CVID patients with various status CD27 expression were activated with SAC and IL-2 in presence of either CD70/300-19 cells expressing CD27 ligand or mock/300-19 as a negative control. In all experiments, the efficiency of the CD27 cross-linking by CD70-transfected cells was checked on B cells obtained from normal individuals (Fig. 5) . As expected, there was no response to CD27 engagement of B cells obtained from patient BG that fail to express CD27 patient FP, Ig production was not increased by CD27 cross-
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linking, whereas in patient JCT, a response similar to normal these mechanisms in the subset of patients where no B cell CD27 expression is inducible after in vitro activation. Since controls was observed.
Taken together, our results suggest that defective CD27 these patients appear to have no circulating CD27 ϩ B cells, it could be argued that the CD27 up-regulation obtained with signaling is frequent in CVID.
the other patients results from the in vitro expansion of CD27 ϩ B cells. We do not favor this interpretation, because the CD27 Discussion induction on CD27 -separated B cells has been previously clearly established (8) . One may also consider an alternative B cell responses are driven by T lymphocytes through cell contacts and cytokine production. We recently identified two hypothesis for the reduced number of CD27 ϩ B cells in CVID: CD27 might be normally induced on these patient B cells B cell co-receptors for T cell activation-induced ligands, CD27 and CD134L, leading to plasma cell differentiation and highand trigger an abnormally high rate of apoptosis shrinking the CD27 ϩ B cell pool. We have previously shown that CD27 rate antibody production respectively (6, 18) . Thus, we decided to investigate the expression and function of these cytoplasmic tail binds the protein Siva and that Siva has two isoforms, one of them, Siva-1, leading to apoptosis (29) . The two receptor-ligand pairs in CVID, a disease characterized by defective antibody responses and absence of plasma cell outcome of CD27 signaling requires a fine tuning between the differential binding of the two isoforms that might be ill differentiation. We found normal induction of CD70 and CD134 on in vitro activated T cells but showed that B cell CD27 balanced in CVID. The second group of CVID patients that we and Brouet expression or function are impaired in a subset of CVID patients.
et al. (25) identified displays a normal number of CD27 ϩ B cells. In these patients, B cell peripheral differentiation seems Our report confirms and extends results recently published by Brouet et al. when we were writing this manuscript (25).
to be able to proceed one step further. Yet, some of them have an abnormal CD27 function, since in both series patients CVID patients can indeed be separated in two groups, one with a normal number of circulating CD27 ϩ B cells and one can be found whose B cells are unresponsive to the CD70/300-19 cells transfected with CD27 ligand. This finding suggests a with a decreased, sometimes markedly, number of CD27 ϩ B cells. Moreover, we showed that patients with a low CD27 ϩ defect in the as-yet uncharacterized CD27 signaling pathway leading to plasma cell differentiation. Looking at CD27, there-B cell pool have a more severe immunodeficiency with profound hypo-γ-globulinemia at the time of diagnosis and fore, confirms the heterogeneous immunologic background of CVID since at least three patient profiles can be distingureduced number of B cells, the later being associated with higher mortality in CVID (26). CD27 is an important differentiished, i.e. low CD27 expression on B cells, normal expression with defective signaling and absence of CD27 abnormalities. ation marker acquired in secondary lymphoid organs during the process of peripheral B cell maturation in response to
In total, our data provide evidence that a B cell defect in CD27 expression or signaling contributes to the altered antigens and the absence of CD27 ϩ B cells may indicate an impairment of peripheral B cell maturation contributing to this plasma cell differentiation in subsets of CVID patients and shed some light on the importance of CD27 function in B severe form of CVID. Interestingly, Lé vy et al. reported that a subgroup of CVID has a defect in Ig V H gene somatic cell biology. hypermutation (27). It will be important to determine whether these patients correspond to those displaying a reduced Acknowledgements CD27 ϩ B cell pool. The precise sequence of molecular events inducing somatic hypermutation or up-regulating CD27 is still CVID identified in this study, a constitutive B cell defect impairs the T-B cross-talk leading to the acquisition of a memory B cell phenotype, including CD27 expression and Ig References V gene somatic hypermutation. In this perspective, it is worth
